Effect of Cinobufagin Injection on Prevention of Recurrence of Primary Liver Cancer with Radical Resection
|更新时间:2024-01-04
|
Effect of Cinobufagin Injection on Prevention of Recurrence of Primary Liver Cancer with Radical Resection
Chinese Journal of Experimental Traditional Medical FormulaeVol. 18, Issue 22, Pages: 307-309(2012)
作者机构:
作者简介:
基金信息:
DOI:
CLC:
Published:2012
稿件说明:
移动端阅览
SONG Gui-ping. Effect of Cinobufagin Injection on Prevention of Recurrence of Primary Liver Cancer with Radical Resection[J]. Chinese journal of experimental traditional medical formulae, 2012, 18(22): 307-309.
DOI:
SONG Gui-ping. Effect of Cinobufagin Injection on Prevention of Recurrence of Primary Liver Cancer with Radical Resection[J]. Chinese journal of experimental traditional medical formulae, 2012, 18(22): 307-309.DOI:
Effect of Cinobufagin Injection on Prevention of Recurrence of Primary Liver Cancer with Radical Resection
Objective:To investigate the effect of Cinobufagin injection on prevention of recurrence of primary liver cancer with radical resection. Method: Sixty postoperative patients with primary liver cancer were randomly divided into three groups: Cinobufagin group
transcatheter arterial chemoembolization (TACE) group and combined treatment group(Cinobufagin+TACE). Each group contained 20 cases. The patients with radical resection after 1 month were given with the corresponding treatment. The life quality
side-effects
survival and recurrence rate in the patients were evaluated. Result: The improvement rates of life quality in Cinobufagin group and combined treatment group were 55.0% and 50.0%
respectively
which were obviously higher than that of TACE group (30.0%
P<0.05). The patients in Cinobufagin group showed the slight side-effects. The over-24-month survival rates of Cinobufagin group and combined treatment group were 75.0% and 70.0%
respectively
which were significantly higher than that of TACE group (60.0%
P<0.05). The over-24-month recurrence rates of three groups showed no difference statistically. Conclusion: Cinobufagin injection is an effective medicine for prevention of recurrence of primary liver cancer with radical resection
Mechanism of Shenqi Yiliu Prescription Combined with Cisplatin on H22 Liver Cancer-bearing Mice Based on NLRP3/Caspase-1/GSDMD Pyroptosis Pathway
Clinical Effect of Fangfeng Tongshengsan on Post-chemoembolization Syndrome with Primary Liver Cancer or Postoperative Liver Metastases of Colorectal Cancer
Efficacy Evaluation of Biejiajianwan in the Treatment of Primary Liver Cancer Based on Real-world Data of Traditional Chinese Medicine
Modified Tuoli Xiaodusan-assisted Treatment of Hp-positive Peptic Ulcer
Data Mining-Based Macroscopic Exploration of Clinical Medication of Chinese Medicine for Liver Cancer
Related Author
YANG Mengying
DUAN Yongqiang
JIA Yuxin
BAI Min
ZHU Zhongbo
LI Yarong
MA Lan
ZHANG Mingyu
Related Institution
General Hospital of Ningxia Medical University
Gansu Province Experimental Animal Industry Technology Center
Key Laboratory of Study on Integrated Traditional Chinese and Western Medicine with High Incidence Diseases in Ningxia
Key Laboratory of Ministry of Education of Traditional Chinese Medicine Prevention and Treatment of High-Incidence Diseases in Ningxia
Basic Medical College,Gansu University of Chinese Medicine